World's Best Scientists 2026 revealed!
Winald R. Gerritsen

Winald R. Gerritsen

D-Index & Metrics

Biology and Biochemistry

D-Index
58
Citations
15704
World Ranking
12994
National Ranking
323

Winald R. Gerritsen publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Winald R. Gerritsen sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 273 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Winald R. Gerritsen D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Winald R. Gerritsen sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 58 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Winald R. Gerritsen is affiliated with Radboud University in the Netherlands and has a strong research profile primarily within the field of Medicine, with a particular focus on Oncology. Their scholarly contributions encompass several subfields including Oncology, Surgery, Pulmonary and Respiratory Medicine, Immunology, and Molecular Biology.

Their research primarily concentrates on core topics such as Cancer Immunotherapy and Biomarkers, Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, Urinary and Genital Oncology Studies, and CAR-T cell therapy research.

Among their recent publications are the following notable papers:

  • Lactate dehydrogenase: a marker of diminished antitumor immunity (2020, OncoImmunology)
  • Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors (2020, European Urology)
  • Strong vaccine responses during chemotherapy are associated with prolonged cancer survival (2020, Science Translational Medicine)
  • Detection and localization of early- and late-stage cancers using platelet RNA (2022, Cancer Cell)
  • Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial (2020, Cancer Immunology Immunotherapy)

Frequent coauthors who have collaborated extensively with Gerritsen include:

  • Niven Mehra
  • I. Jolanda M. de Vries
  • Rutger H.T. Koornstra
  • Sandra van Wilpe
  • Carl G. Figdor

Gerritsen's work has been published across several key venues, evidencing a breadth of contribution to medical and oncological literature. These venues include:

  • Annals of Oncology
  • Cancers
  • OncoImmunology
  • European Urology
  • Cancer Immunology Immunotherapy

Best Publications

  • Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

    Joaquim Bellmunt;Ronald De Wit;David J. Vaughn;Yves Fradet

  • Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

    Charles J. Ryan;Matthew R. Smith;Johann S. De Bono;Arturo Molina

  • Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial

    Eugene D. Kwon;Charles G. Drake;Howard I. Scher;Karim Fizazi

  • Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer

    Tomasz M. Beer;Eugene D. Kwon;Charles G. Drake;Karim Fizazi

  • Therapeutic vaccines for cancer: an overview of clinical trials

    Ignacio Melero;Gustav Gaudernack;Winald Gerritsen;Christoph Huber

  • Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

    Alfons J M van den Eertwegh;Jurjen Versluis;H Pieter van den Berg;Saskia J A M Santegoets

  • Blood platelets contain tumor-derived RNA biomarkers

    R. Jonas A. Nilsson;R. Jonas A. Nilsson;Leonora Balaj;Leonora Balaj;Esther Hulleman;Sjoerd van Rijn

  • Dendritic Cell–Based Immunotherapy: State of the Art and Beyond

    Kalijn F. Bol;Gerty Schreibelt;Winald R. Gerritsen;I. Jolanda M. de Vries

  • Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up

    Y Fradet;J Bellmunt;D J Vaughn;J L Lee

  • Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma.

    Mario Sznol;Pier Francesco Ferrucci;David Hogg;Michael B Atkins

  • Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells

    Gerty Schreibelt;Kalijn F. Bol;Harm Westdorp;Florian Wimmers

  • Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer.

    James L Gulley;Michael Borre;Nicholas J Vogelzang;Siobhan Ng

  • Targeting of adenoviral vectors through a bispecific single-chain antibody

    Hidde J Haisma;Jacques Grill;Jacques Grill;David T Curiel;David T Curiel;Susan Hoogeland

  • Virus-directed enzyme prodrug therapy : intratumoral administration of a replication-deficient adenovirus encoding nitroreductase to patients with resectable liver cancer

    Daniel H. Palmer;Vivien Mautner;Darius Mirza;Simon Oliff

  • Conditionally replicative adenovirus expressing p53 exhibits enhanced oncolytic potency.

    Victor W van Beusechem;Petra B van den Doel;Jacques Grill;Herbert M Pinedo

  • Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAM

    H. J. Haisma;H. M. Pinedo;A. Van Rijswijk;I. Van Der Meulen-Muileman

  • Immunogenicity, Including Vitiligo, and Feasibility of Vaccination With Autologous GM-CSF–Transduced Tumor Cells in Metastatic Melanoma Patients

    Rosalie M. Luiten;Esther W.M. Kueter;Wolter Mooi;Maarten P.W. Gallee

  • Hepatocyte Growth Factor/Scatter Factor Promotes Adhesion of Lymphoma Cells to Extracellular Matrix Molecules Via α4β1 and α5β1 Integrins

    Iris S. Weimar;Daphne de Jong;Egbert J. Muller;Toshikazu Nakamura

  • Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time.

    Wouter W. van Willigen;Martine Bloemendal;Winald R. Gerritsen;Gerty Schreibelt

  • Lactate dehydrogenase: a marker of diminished antitumor immunity

    Sandra Van Wilpe;Rutger Koornstra;Martijn Den Brok;Jan Willem De Groot

Frequent Co-Authors

I. Jolanda M. de Vries
I. Jolanda M. de Vries Radboud University
Carl G. Figdor
Carl G. Figdor Radboud University
Gerty Schreibelt
Gerty Schreibelt Radboud University
David I. Quinn
David I. Quinn University of Southern California
Yves Fradet
Yves Fradet Université Laval
Dean F. Bajorin
Dean F. Bajorin Memorial Sloan Kettering Cancer Center
Joaquim Bellmunt
Joaquim Bellmunt Beth Israel Deaconess Medical Center
Jack A. Schalken
Jack A. Schalken Radboud University
Lawrence Fong
Lawrence Fong University of California, San Francisco
Cora N. Sternberg
Cora N. Sternberg Cornell University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a degree in Biology or Biochemistry opens the door to many rewarding careers in healthcare, research, and allied sciences. For students considering alternative or supplementary qualifications, there are numerous related online programs to help jumpstart or advance your career.

Those interested in advanced nursing roles may want to look into post masters fnp programs, which provide fast, flexible pathways for registered nurses to become Family Nurse Practitioners.

Nutrition is another high-demand field. Earning a dietitian degree online is a budget-friendly way to qualify for nutritionist or dietitian roles, helping clients achieve their health goals.

Many biology and biochemistry graduates pursue nursing as a career. If you’re already a registered nurse and ready to take the next step, an easiest rn to bsn online program can offer the flexibility you need to further your credentials and boost your career opportunities.

Those seeking leadership roles in healthcare may opt for a fastest online master's in healthcare management to develop essential business and management skills for the modern medical sector.

Best Scientists Citing Winald R. Gerritsen

Trending Scientists

Recently Published Articles